Danaher had a disappointing 2024. Your path to success next year passes through Wall Street
Life sciences company Danaher certainly hasn't been an easy stock to buy this year. A wave of new companies going…
health care industry
FDA raises recall alert to highest level for Costco eggs over risk of serious illness or death due to salmonella
Eggs are displayed for sale inside a Costco store in Hawthorne, California, on January 26, 2023. Patricio T. Fallon |…
Digital health stocks will get hit by Wall Street in 2024, but Hims will soar
Doximity on the New York Stock Exchange for its IPO, June 24, 2021. Source: New York Stock Exchange If the…
FDA Approves Eli Lilly's Zepbound Weight-Loss Drug for Sleep Apnea
An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York, U.S., on Thursday, March…
Dexcom launches generative AI platform for Stelo users
The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Light…
Suki and Google Cloud Expand Healthcare Technology Partnership
Healthcare artificial intelligence startup Suki on Wednesday announced a new collaboration with Google cloud as part of its push to…
Merck signs weight loss pills licensing agreement with Hansoh Pharma
Exterior view of the entrance to Merck headquarters on February 5, 2024 in Rahway, New Jersey. Spencer Platt | fake…
Eli Lilly's Zepbound Weight Loss Drug No Longer in Shortage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Ozempic faces scrutiny over possible risk of eye condition
A box of Ozempic manufactured by Novo Nordisk is seen in a pharmacy in London, Britain, March 8, 2024. Hollie…
We're adding to our position in a stock that just got some big support from Wall Street.
Shortly after the bell rings, we will buy 300 shares of Bristol Myers Squibb at approximately $56.50. Following the deal,…